Effect of Repeated Freezing and Thawing on Biomarker Stability in Plasma and Serum Samples  by Lee, Jae-Eun et al.
Osong Public Health Res Perspect 2015 6(6), 357e362
http://dx.doi.org/10.1016/j.phrp.2015.11.005
pISSN 2210-9099 eISSN 2233-6052- ORIGINAL ARTICLE -Effect of Repeated Freezing and Thawing on
Biomarker Stability in Plasma and Serum SamplesJae-Eun Lee a, Shine Young Kim b, So-Youn Shin a,*
aNational Biobank of Korea, Center for Genome Sciences, Korea National Institute of Health, Korea
Centers for Disease Control and Prevention, Chungcheongbuk-do, Korea.
bDepartment of Laboratory Medicine, Pusan National University School of Medicine, Busan, Korea.Received: September
24, 2015
Accepted: November
7, 2015
KEYWORDS:
freezeethaw cycles,
plasma,
pre-analytical variation,
serum,
stability*Corresponding author.
E-mail: leukoso@hanmail.net (S.-Y. Shin)
This is an open-access article distrib
Works License (http://creativecommons
duction in any medium, provided the ori
Copyright ª 2015 Korea Centers for DiseAbstract
Objectives: The stability of circulating proteins can be affected by repeated
freezing and thawing. The aim of our study was to identify the effect of repeated
freezing and thawing on the plasma and serum concentrations of eight proteins
[interferon-g, interleukin (IL)-8, IL-15, IL-17A, matrix metalloproteinase (MMP)-
7, tumor necrosis factor-a, vascular endothelial growth factor (VEGF), and VEGF
receptor 2 (VEGF-R2)].
Methods: We assessed the concentration changes of these proteins in 30 plasma
and serum samples subjected to three, four, or five freezeethaw cycles, and
compared these with the concentration changes in the samples that were sub-
jected to two freezeethaw cycles before analysis.
Results: Repeated freezing and thawing by up to five cycles did not modify the
plasma and serum concentrations of interferon-g, IL-8, and VEGF-R2, while levels
of MMP-7, tumor necrosis factor-a, and VEGF were significantly changed in both
plasma and serum samples. Moreover, MMP-7 and VEGF concentrations tended to
increase with freezeethaw cycles. They were more elevated in plasma samples
(up to about 15%) than in serum samples (up to about 7%), suggesting that serum
is the preferred sample type for the analysis of circulating proteins.
Conclusion: This is the first report on the effect of repeated freezing and
thawing on plasma concentrations of MMP-7 and VEGF-R2. Our findings propose
that researchers should consider the number of freezeethaw cycles to select
plasma or serum samples, depending on the type of analyte.1. Introduction
The plasma and serum proteome, released from
various cells and tissues, reflect the dynamic health.
uted under the terms of th
.org/licenses/by-nc-nd/4.0
ginal author and source are
ase Control and Preventionstatus of human beings [1e4]. Some proteins have been
used as biomarkers for disease prognosis or diagnosis, or
have been studied as candidates for biomarker discov-
ery. For example, serum vascular endothelial growthe Creative Commons Attribution-NonCommercial-No Derivative
) which permits non-commercial use, distribution, and repro-
credited.
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biomarker for various diseases, including cervical can-
cer and acute ischemic stroke [5,6]. Serum tumor ne-
crosis factor-alpha (TNF-a) was reported as a candidate
biomarker of systemic inflammatory response in patients
with chronic obstructive pulmonary disease [7].
Many biobanks collect and store plasma and serum
samples for future biomedical research, including
biomarker discovery. Because these biobanks contain a
limited number of aliquots [8], the samples may undergo
repeated freezing and thawing, thereby causing dena-
turation, aggregation, and functional loss of circulating
proteins [9,10]. Although biobanks are required to
secure and store samples in small aliquots, this is often
impossible due to the sample size and limitations of the
storage space.
Several scientists have studied the pre-analytical
variations of plasma and serum proteins caused by
repeated freezing and thawing to establish standard
operating procedures for the collection, management,
and storage of human biospecimens and to identify
quality assessment biomarkers [9e11]. However, not
much is known about the effect of repeated freezing and
thawing on protein stability. In this study, we assessed
plasma and serum concentration changes of various
proteins induced by repeated freezing and thawing.2. Materials and methods
2.1. Sample preparation
The blood samples remaining after medical exami-
nation were used for this study. Blood samples were
collected in plasma separator tubes (K2 ethyl-
enediaminetetraacetic acid tubes; Becton Dickinson, NJ,
USA) and vacutainer serum separator tubes (Becton
Dickinson). Different aliquots of plasma and serum
samples, obtained after centrifugation at 2,000g for 15
minutes, were pooled (2e3 samples in each pool) to
secure a sufficient amount for analysis and then stored at
75C. Thirty pooled plasma and serum samples were
thawed at 37C and each sample was aliquoted into four
tubes. Among them, one aliquot was stored at 75C,
until it was used for analysis. The remaining aliquots
were additionally thawed one, two, or three times at
37C and frozen again.
2.2. Protein measurement
Plasma and serum concentrations of cytokines and
VEGF (pg/mL) were assessed using the Milliplex Map
Human Cytokine/Chemokine Magnetic Bead Panel kit-
Immunology Milliplex Assay (Millipore, Billerica, MA,
USA), according to the instructions in the manufacturer’s
manual. Cytokine analytes included interleukin (IL)-8,
IL-15, IL-17A, interferon-g (IFN-g), and TNF-a. Plasma
and serum levels of matrix metalloproteinase-7 (MMP-7)
and VEGF receptor 2 (VEGF-R2) were measured usingthe Human Total MMP7 Quantikine ELISA kit and the
Human VEGFR2/KDR Quantikine ELISA kit (R&D
Systems Europe, Lille, France), respectively, in accor-
dance to the manufacturer’s protocol.
2.3. Statistical analysis
Plasma and serum concentrations of analytes are
shown as the mean  standard deviation. The variations
in the analytes due to repeated freezing and thawing for
three, four, or five cycles are expressed as mean per-
centage changes with a “þ” for an increase and a “e”
for a decrease compared with two freezeethaw cycles
(baseline). Statistical significance of these variations
was assessed through repeated-measures analysis of
variance and paired 2-tailed t-test using SPSS version
13.0 (SPSS Inc., Chicago, IL, USA). A p value < 0.05
was regarded as statistically significant.3. Results
We assessed the concentration variations of eight
proteins (IFN-g, IL-8, IL-15, IL-17A, MMP7, TNF-a,
VEGF, and VEGF-R2) in plasma and serum samples that
were repeatedly frozen and thawed for three, four, or five
cycles, and compared these to the concentration varia-
tions in the samples that were subjected to two freeze-
ethaw cycles before analysis (baseline). As shown in
Table 1 and Figure 1, IFN-g, IL-8, IL-15, IL-17A, and
VEGF-R2 were stable in plasma samples throughout
repeated freezing and thawing, whereas the concentra-
tions of MMP-7, TNF-a, and VEGF were significantly
changed.MMP-7 andVEGF levels increased up to>15%
after five freezeethaw cycles and showed a tendency to
increase with the number of freezeethaw cycles. TNF-a
levels significantly decreased (approximately 3%) after
five freezeethaw cycles.
In the case of serum samples, IFN-g, IL-8, and
VEGF-R2 levels did not change significantly during
repeated freezeethaw cycles, whereas the concentra-
tions of IL-15, IL-17A, MMP7, TNF-a, and VEGF
increased or decreased significantly during the freezing
and thawing process (Table 2, Figure 2). As in plasma
samples, MMP-7 and VEGF levels showed a tendency
to increase with freezeethaw cycles in serum samples;
however, the increase was more limited than in plasma
samples.4. Discussion
In this study, we assessed whether the plasma and
serum concentrations of eight different proteins are
affected by repeated freezing and thawing. The levels of
IFN-g, IL-8, and VEGF-R2 were stable in both plasma
and serum samples during repeated freezeethaw cycles
in our experimental conditions. There are a few reports
Table 1. Concentration changes of analytes induced by repeated freezing and thawing of plasma samples.
Analyte
(pg/mL)
Freezeethaw cycles
p2 cycles (baseline) 3 cycles* 4 cycles* 5 cycles*
IFN-g 6.14  8.80 6.07  7.74 5.49  5.17 5.45  6.05 0.205
(e1.2) (e10.6) (e11.3)
IL-8 96.35  164.46 96.82  164.79 93.96  154.99 94.58  159.41 0.548
(þ0.5) (e2.5) (e1.8)
IL-15 1.70  1.05 1.72  1.00 1.69  1.11 1.67  1.26 0.963
(þ1.0) (e0.7) (e1.7)
IL-17A 1.24  1.59 1.20  1.54 1.13  1.36 1.084  1.21 0.495
(e3.7) (e9.4) (e13.1)
MMP7 2.34  1.91 2.57  2.11y 2.64  2.18y 2.71  2.03y <0.001
(þ9.9) (þ12.5) (þ15.6)
TNF-a 48.55  49.42 47.48  47.41 47.56  47.69 47.02  47.56y 0.072
(e2.2) (e2.0) (e3.2)
VEGF 134.39  80.64y 144.40  90.81y 148.67  97.15y 154.69  104.38y 0.124
(þ7.4) (þ10.6) (þ15.1)
VEGFR2 7,292.03  878.64 7,259.46  833.46 7,266.65  866.95 7,278.96  850.16 0.903
(e0.4) (e0.3) (e0.2)
*Values within“( )” show the percentage change with a “þ” for an increase and a “e” for a decrease compared with baseline; yIndicates p < 0.05 calculated
using paired 2-tailed t test. The p value was measured using repeated-measures analysis of variance. IFNZ interferon; ILZ interleukin; MMPZ matrix
metalloproteinase; TNF Z tumor necrosis factor; VEGF Z vascular endothelial growth factor.
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and serum concentrations of IFN-g, IL-8, and VEGF-R2
[9,12e14], except for the plasma concentration of
VEGF-R2. Our findings are concordant with these
publications, showing that these proteins are not sus-
ceptible to degradation induced by repeated freeze-
ethaw cycles. In addition, we determined for the first
time that VEGF-R2 is also stable in plasma samples
during repeated freezeethaw cycles. IFN-g, IL-8, and
VEGF-R2 have attracted attention as new biomarkers of
various diseases such as ovarian carcinoma, urinary
bladder cancer, acute pyelonephritis, osteoarthritis, or
rheumatoid arthritis [15e20]. Our study shows that
these may become stable biomarkers, which can be used
for diagnosis or prediction of prognosis, regardless of
repeated freezing and thawing of samples.
MMP-7, TNF-a, and VEGF levels were significantly
changed in both plasma and serum samples during
repeated freezeethaw cycles. MMP7 and VEGF levels
were elevated by approximately 15% in plasma samples
and by 7% in serum samples after five freezeethaw cycles,
compared with two freezeethaw cycles. MMP7 and
VEGF levels showed a tendency to increase with freeze-
ethaw cycles. In a previous study, changes in the MMP-7
level induced by repeated freezing and thawing were
determined in serum samples [9], concordant with our
results.We identified for the first time that theMMP7 level
was elevated by repeated freezing and thawing in serum as
well as in plasma samples.MMP7has attracted attention as
a new biomarker for cancer, joint diseases, and liver dis-
eases [21e23]. Concentrations of MMP7 are increased inthe serum of rheumatoid arthritis patients with interstitial
lung disease [22] and in the plasma of patients with
asymptomatic interstitial lung disease [21]. Therefore, we
recommend that researchers should consider the number of
freezeethaw cycles to select plasma or serum samples for
MMP7 analysis. Azimi-Nezhad et al [24] reported that
plasma VEGF levels changed as a result of repeated
freezing and thawing. Guo et al [13] identified that con-
centrations of VEGF did not change in the plasma samples
for up to 10 freezeethaw cycles, compared with unfrozen
samples, whichwas in contrast to our results. Guo et al [13]
collected whole blood into lithium heparin tubes, unlike
our and other studies, which use ethylenediaminetetra-
acetic acid tubes. Taken together, these facts indicate that
the effect of repeated freezing and thawing on the stability
of plasma VEGF may be different depending on the tube
type used for sample collection. In the case of serum, it has
been reported that VEGF levels are not affected by
repeated freezing and thawing [13,24]; however, our study
shows that VEGF levels were slightly elevated after five
freezeethaw cycles. We thawed serum samples at 37C,
but in other studies, samples were thawed at room tem-
perature, implying that the thawing temperature of serum
samples may influence the stability of circulating proteins.
Thus, sample thawing should occur at temperatures as low
as possible. In addition, we determined that serum con-
centrations ofMMP-7 andVEGF are less affected than that
in plasma samples, suggesting that serum is the preferred
sample for the analysis of circulating proteins.
In conclusion, our study shows the different effects of
repeated freezing and thawing on the stability of eight
Figure 1. Box plot showing the effect of repeated freezing and thawing on plasma concentrations of analytes. Lines on the box
plot represent the median, 1st, and 3rd quartiles. Vertical lines represent the 10th and 90th centiles. IFN Z interferon;
ILZ interleukin; MMPZ matrix metalloproteinase; TNFZ tumor necrosis factor; VEGFZ vascular endothelial growth factor.
Table 2. Concentration changes of analytes induced by repeated freezing and thawing of serum samples.
Analyte
(pg/mL)
Freezeethaw cycles
p2 cycles (baseline) 3 cycles* 4 cycles* 5 cycles*
IFN-g 8.11  12.98 8.66  14.13 8.82  14.71 8.36  13.76 0.327
(þ6.8) (þ8.8) (þ3.2)
IL-8 35.54  71.31 36.25  71.46 36.40  71.28 34.22  67.01 0.208
(þ2.0) (þ2.4) (e3.7)
IL-15 1.54  0.74 1.67  0.73y 1.73  0.71y 1.46  0.66 0.001
(þ8.7) (þ12.4) (e4.7)
IL-17A 3.07  3.45 3.59  4.06y 3.29  3.61 3.02  3.39 0.110
(þ17.2) (þ7.4) (e1.6)
MMP7 2.48  1.50 2.59  1.57y 2.65  1.43y 2.64  1.41y 0.004
(þ4.1) (þ6.9) (þ6.5)
TNF-a 8.74  5.09 9.04  5.63y 9.17  5.80y 8.82  5.57 0.126
(þ3.4) (þ4.9) (þ0.9)
VEGF 195.13  99.52 197.53  97.88 197.21  97.99 208.84  108.75y 0.107
(þ1.2) (þ1.1) (þ7.0)
VEGFR2 9,230.32  1,877.97 9,264.60  1,874.35 9,237.86  1,806.16 9,267.74  1,845.64 0.877
(þ0.4) (þ0.1) (þ0.4)
*Values within“( )” show the percentage change with a “þ” for an increase and a “e” for a decrease compared with baseline; yIndicates p < 0.05 calculated
with paired 2-tailed t test. The p value was measured with repeated-measures analysis of variance. IFN Z interferon; IL Z interleukin; MMP Z matrix
metalloproteinase; TNF Z tumor necrosis factor; VEGF Z vascular endothelial growth factor.
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Figure 2. Box plot showing the effect of repeated freezing and thawing on serum concentrations of analytes. Lines on the box
plot represent the median, 1st, and 3rd quartiles. Vertical lines represent the 10th and 90th centiles. IFN Z interferon;
ILZ interleukin; MMPZ matrix metalloproteinase; TNFZ tumor necrosis factor; VEGFZ vascular endothelial growth factor.
Biomarker stability 361circulating proteins. IFN-g, IL-8, and VEGF-R2 are not
susceptible to freezeethawing-induced protein concen-
tration changes, while MMP7, TNF-a, and VEGF are
slightly susceptible. Furthermore, we identified that the
tube type used for collection of whole blood and the
thawing temperature of samples may influence the sta-
bility of the circulating proteins. We believe that these
findings will aid in sample selection according to the
type of analyte and in the further development of stan-
dard operating procedures for biobanking.Conflicts of interest
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